AstraZeneca: All eyes on delisting plan

AstraZeneca Pharma India shares will see higher activity next week, as its board of directors will meet on April 15 to consider seeking shareholders approval for delisting proposal through postal ballot. Earlier on March 15, the board had approved the proposal received from its promoter AstraZeneca Pharmaceuticals AB, Sweden. After having failed in its earlier two attempts, it would be interesting to know whether this time the company will succeed in its delisting move.